Sandoz, Momenta allege misconduct by Amphastar in enoxaparin antitrust suit
Sandoz and Momenta Pharmaceuticals have asked a federal court to sanction rival Amphastar after the company’s outside lawyers leaked sensitive business documents obtained in patent-antitrust litigations to Amphastar executives. Those same...To view the full article, register now.
Already a subscriber? Click here to view full article